Xilio Therapeutics
Waltham, United States · $225.5M raised
- Headquarters
- Waltham, Massachusetts
- Business Model
- B2B
- Website
- xiliotx.com
- Total Funding
- $225.5M
- Last Round
- $95.0M Series CFeb 2021
- Rounds
- 3
About
Clinical-stage biotechnology company developing tumor-activated immuno-oncology therapies for cancer treatment.
Summary
Xilio Therapeutics is a Biotech company based in Waltham, United States. It has raised $225.5M in total across 3 rounds, most recently a $95.0M Series C round in Feb 2021. Investors include SV Health Investors, Coastlands Capital and Frazier Life Sciences.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...